Duo Liu | Epidemiology | Best Researcher Award

Published on by Health Scientists

Prof. Duo Liu | Epidemiology | Best Researcher Award 

Deputy Director, Department of Clinical Pharmacy | Harbin Medical University | China

Professor Duo Liu, Chief Pharmacist and Doctoral Supervisor at Harbin Medical University Cancer Hospital, is a distinguished pharmaceutical scientist whose research has significantly advanced the fields of pharmacogenomics, pharmacoepidemiology, and precision oncology. With a strong background in medical genetics and pharmacology, Professor Liu has developed a research portfolio that bridges molecular pharmacology with clinical translation, focusing on the genetic mechanisms underlying cancer susceptibility, therapeutic response, and drug resistance. His pioneering contributions include transcriptome-wide association studies identifying novel genetic determinants of pancreatic and prostate cancer risk, as well as investigations into the role of NADPH oxidase polymorphisms and oxidative stress in tumor biology and treatment outcomes. Professor Liu’s scholarly work, published in leading international journals such as Cancer Research, Carcinogenesis, and International Journal of Cancer, has garnered wide recognition for its methodological rigor and clinical relevance. He has successfully led multiple national and institutional research grants, including projects supported by the National Natural Science Foundation of China, and has been honored with several prestigious distinctions for excellence in pharmaceutical sciences and young investigator achievements. As an active member of numerous professional societies, including the Chinese Pharmacological Society and the Anti-Cancer Association of China, Professor Liu contributes to shaping the evolving landscape of cancer pharmacotherapy and drug epidemiology. His collaborations with global research institutions, notably the University of Hawaii Cancer Center, underscore his commitment to advancing international scientific exchange and translational medicine. Through his leadership in clinical pharmacy and mentorship of emerging scientists, Professor Liu continues to drive innovation in personalized cancer treatment and rational drug use, promoting evidence-based healthcare practices that enhance patient outcomes and public health impact worldwide.

Profile: ORCID 

Featured Publications

1. Chen, C., Dong, Q., Wang, H., Dong, S., Wang, S., Lin, W., Jia, C., Dong, M., Jin, Y., & Liu, D. (2025, January 8). The association between NADPH oxidase (NOX) polymorphisms with immunohistochemistry and survival in diffuse large B cell lymphoma patients. Annals of Hematology.

2. Wang, S. F., Dong, S. Q., Dong, Q., Lin, W. X., Dong, M., & Liu, D. (2024). Natural product-induced oxidative stress-synergistic anti-tumor effects of chemotherapeutic agents. Traditional Medicine Research.

3. Dong, S., Chen, C., Di, C., Wang, S., Dong, Q., Lin, W., & Liu, D. (2024, December). The association between NADPH oxidase 2 (NOX2) and drug resistance in cancer. Current Cancer Drug Targets.

4. Liu, D., Bae, Y. E., Zhu, J., Zhang, Z., Sun, Y., Deng, Y., Wu, C., & Wu, L. (2023, December 15). Splicing transcriptome-wide association study to identify splicing events for pancreatic cancer risk. Carcinogenesis.

5. Liu, D., Zhao, T., Zhu, J., Sharapov, S., Tiys, E., & Wu, L. (2023, December 4). Associations between genetically predicted plasma N-glycans and pancreatic cancer risk. All Life.

Suresh Arumugam | Infectious Diseases | Best Researcher Award

Published on by Health Scientists

Dr. Suresh Arumugam | Infectious Diseases | Best Researcher Award

Scientist | Meenakshi Medical College Hospital and Research Institute | India

Dr. A. Suresh is a distinguished microbiologist and currently serves as Scientist cum Research Coordinator at the Central Research Laboratory, Meenakshi Medical College Hospital & Research Institute, Kanchipuram, with over 17 years of academic experience and 9 years of corporate expertise. He holds a Ph.D. in Microbiology from the University of Madras, an M.Phil. in Biotechnology from Bharathidasan University, and an M.Sc. in Applied Microbiology from Sri Sankara Arts and Science College under the University of Madras. His primary research areas span infectious diseases, antimicrobial resistance, natural product-based drug discovery, and genome annotation, where he has significantly contributed through genomic data submissions, innovative patents, and translational studies. Dr. Suresh has authored and co-authored more than 70 peer-reviewed publications in high-impact journals including the Journal of Medical Virology, Molecular Biology Reports, Drug Delivery Science and Technology, and Luminescence, highlighting his multidisciplinary expertise across microbiology, biotechnology, and clinical research. His scientific contributions have been recognized through several awards, including distinctions for innovation in natural product drug discovery and his leadership in antimicrobial stewardship. Beyond his research, Dr. Suresh has played a pivotal role as Ph.D. supervisor, doctoral committee member, and academic coordinator, mentoring young researchers and advancing scientific education. He also contributes to the wider scientific community as an editorial board member and peer reviewer for reputed international journals, ensuring the dissemination of high-quality research. Dr. Suresh’s career embodies a balance of scientific discovery, innovation, and academic mentorship, positioning him as a thought leader in microbiology and drug discovery research. He has 360 citations from 68 documents with an h-index of 8.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Mohan, K., Srinivasan, S., Selvaraj, S., Suresh, A., & Krishnamoorthy, A. (2025). A study on dengue infection, seroprevalence and its seasonal distribution among patients attending a tertiary care hospital, Kanchipuram, India. Journal of Applied Pharmaceutical Science.

2. Kaliaperumal, K., Aboobacker, J., Dhanapal, V., Gayathri, A., Subramanian, K., Suresh, A., Elumalai, S., Sampath, S., Devanesan, S., AlSalhi, M. S., et al. (2025). Bioremediation of malachite green dye using Sargassum wightii seaweed and its biological and physicochemical characterization. Open Chemistry.

3. Kamalanathan, J., Suresh, M. S., Rajendran, V., AlSalhi, M., Devanesan, S., Suresh, A., Joseph, J., & Sampath, S. (2025). Nuclear staining and fluorogenic probe–based evaluation of ROS-cytotoxic potential using AgNPs synthesized from Cajanus trinervius against A431 cell line. Luminescence.

4. Suresh, A., Muninathan, N., Sampath, S., Devanesan, S., AlSalhi, M. S., & Manoj, D. (2025). Role of traditional and new biomarkers in the assessment of chronic kidney diseases: A comprehensive analysis of the biochemical, molecular and clinical dimensions. Molecular Biology Reports.

5. Rajeswari, M. V., Suresh, A., Thirumalaikumar, E., Subramanian, K., Kaliaperumal, K., Sampath, S., Devanesan, S., & AlSalhi, M. S. (2025). Efficacy of chitosan conjugated bivalent vaccine on immune response and disease resistance against Aeromonas hydrophila and Aeromonas caviae in goldfish (Carassius auratus). Journal of Drug Delivery Science and Technology.

6. Christina, B., Poongkuzhali, S., Muninathan, N., Bhaskaran, K., & Suresh, A. (2025). The mechanisms and therapeutic potential of the microbiome-immune interface in cancer. Discover Biotechnology.